共 74 条
[61]
Alter G., Hatzakis G., Tsoukas C.M., Et al., Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection, J Immunol, 71, pp. 477-488, (2003)
[62]
Zaunders J.J., Munier M.L., Kaufmann D.E., Et al., Early proliferation and loss of CCR5(+)CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection, Blood, 106, pp. 1660-1667, (2005)
[63]
Harari A., Vallelian F., Pantaleo G., Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load, Eur J Immunol, 34, pp. 3525-3533, (2004)
[64]
Lichterfeld M., Kaufmann D.E., Yu X.G., Et al., Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells, J Exp Med, 200, pp. 701-712, (2004)
[65]
Richman D.D., Wrin T., Little S.J., Petropoulos C.J., Rapid evolution of the neutralizing antibody response to HIV type 1 infection, Proc Natl Acad Sci U S A, 100, pp. 4144-4149, (2003)
[66]
Malhotra U., Holte S., Zhu T., Et al., Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection, J Virol, 77, pp. 2663-2674, (2003)
[67]
Appay V., Zaunders J.J., Papagno L., Et al., Characterization of CD4+ cytotoxic T lymphocytes ex vivo, J Immunol, 168, pp. 5954-5958, (2002)
[68]
Zaunders J.J., Dyer W.B., Wang B., Et al., Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection, Blood, 103, pp. 2238-2247, (2004)
[69]
Amyes E., Hatton C., Montamat-Sicotte D., Et al., Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection, J Exp Med, 198, pp. 903-911, (2003)
[70]
Savoldo B., Ciubbage M.L., Durett A.G., Et al., Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals, J Immunol, 168, pp. 909-918, (2002)